Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone Caproate (vol 348, pg 2379, 2003)

Prevention of Recurrent Preterm Delivery by 17 Alpha-Hydroxyprogesterone Caproate (N Engl J Med 2003;348:2379-2385). In the Results section of the Abstract (page 2379), the first sentence should have begun, "Base-line characteristics of the 310 women in the 17P group," rather than "... of the 310 women in the progesterone group." In the second sentence, the first parenthetical should have begun, "(incidence, 36.3 percent in the 17P group," rather than "... in the progesterone group." In the second paragraph of the Introduction (page 2380), the penultimate sentence should have begun, "Another meta-analysis, restricted to trials of 17 alpha-hydroxyprogesterone caproate (17P), a synthetic progestogen," rather than "... a synthetic form of progesterone." In the running heads . . .